1. "Myeloma"
Formats
  1. Meeting Abstract (543)
  2. Journal Article (358)
  3. Review (36)
  4. Research Letter (19)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (6)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)

More Groups

People
  1. Alexander Lesokhin (363)
  2. Carl Landgren (336)
  3. Hani Hassoun (329)
  4. Sham Mailankody (282)
  5. Malin Hultcrantz (260)
  6. Heather Landau (239)

More People

Years
  1. 2025 (13)
  2. 2024 (69)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (303)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (85)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (22)

More Publications

Publishers
  1. American Society of Hematology (324)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (87)
  4. Nature Publishing Group (83)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (988)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Multiple myeloma, version 1.2020: Featured updates to the NCCN guidelines
    Guidelines

    Kumar, S. K.; Callander, N. S.; Hillengass, J.; Liedtke, M.; Baljevic, M.; Campagnaro, E.; Castillo, J. J.; Chandler, J. C.; Cornell, R. F.; Costello, C.; more...
    Journal of the National Comprehensive Cancer Network (2019)

    Fulltext@MSK | Save
  • Humanistic and economic impact of subcutaneous versus intravenous administration of oncology biologics
    Review

    Anderson, K. C.; Landgren, O.; Arend, R. C.; Chou, J.; Jacobs, I. A.
    Future Oncology (2019)

    Fulltext@MSK | Save
  • Delaying the use of high-dose melphalan with stem cell rescue in multiple myeloma is ready for prime time
    Review

    Kazandjian, D.; Landgren, O.
    Clinical Advances in Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • HORIZON (OP-106) study of melflufen in patients with relapsed/refractory multiple myeloma (RRMM) refractory to daratumumab and/or pomalidomide: Updated efficacy and safety
    Meeting Abstract

    Richardson, P. G.; Oriol, A.; Larocca, A.; Otero, P. R.; Norkin, M.; Bladé, J.; Cavo, M.; Hassoun, H.; Leleu, X.; Alegre, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • Plasma cell immunophenotypic abnormalities as predictors of progression in patients with monoclonal gammopathy of undetermined significance and smoldering plasma cell myeloma
    Meeting Abstract

    Galera, P.; Sun, X.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Kazandjian, D.; Maric, I.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Carfilzomib with immunomodulatory drugs for the treatment of newly diagnosed multiple myeloma
    Review

    Landgren, O.; Sonneveld, P.; Jakubowiak, A.; Mohty, M.; Iskander, K. S.; Mezzi, K.; Siegel, D. S.
    Leukemia (2019)

    Fulltext@MSK | Save
  • Association of immune marker changes with progression of monoclonal gammopathy of undetermined significance to multiple myeloma
    Journal Article

    Landgren, O.; Hofmann, J. N.; McShane, C. M.; Santo, L.; Hultcrantz, M.; Korde, N.; Mailankody, S.; Kazandjian, D.; Murata, K.; Thoren, K.; more...
    JAMA Oncology (2019)

    Fulltext@MSK | Save
  • Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies
    Journal Article

    Cohen, A. D.; Garfall, A. L.; Dogan, A.; Lacey, S. F.; Martin, C.; Lendvai, N.; Vogl, D. T.; Spear, M.; Lesokhin, A. M.
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Plasma cell immunophenotypic abnormalities as predictors of progression in patients with monoclonal gammopathy of undetermined significance and smoldering plasma cell myeloma
    Meeting Abstract

    Galera, P.; Sun, X.; Yuan, C.; Stetler-Stevenson, M.; Landgren, O.; Kazandjian, D.; Maric, I.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Lessons learned from checkpoint blockade targeting PD-1 in multiple myeloma
    Review

    Lesokhin, A. M.; Bal, S.; Badros, A. Z.
    Cancer Immunology Research (2019)

    Fulltext@MSK | Save